These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24223884)

  • 21. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
    Mader S; Lutterotti A; Di Pauli F; Kuenz B; Schanda K; Aboul-Enein F; Khalil M; Storch MK; Jarius S; Kristoferitsch W; Berger T; Reindl M
    PLoS One; 2010 May; 5(5):e10455. PubMed ID: 20463974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
    Waters P; Vincent A
    Int MS J; 2008 Sep; 15(3):99-105. PubMed ID: 18808744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
    Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
    McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Hinson SR; Kryzer TJ; Lucchinetti CF; Weinshenker BG; Wingerchuk DM; Shuster EA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1134-8. PubMed ID: 19752303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder.
    Kang ES; Min JH; Lee KH; Kim BJ
    Ann Lab Med; 2012 Sep; 32(5):331-8. PubMed ID: 22950068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of anti-aquaporin 4 antibody in neuromyelitis optical].
    Liao ZY; Ye J; Sun H; You XF; Guan YQ
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):1012-5. PubMed ID: 23886267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.
    Sánchez Gomar I; Díaz Sánchez M; Uclés Sánchez AJ; Casado Chocán JL; Suárez-Luna N; Ramírez-Lorca R; Villadiego J; Toledo-Aral JJ; Echevarría M
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
    Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
    Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis.
    Jiao Y; Fryer JP; Lennon VA; McKeon A; Jenkins SM; Smith CY; Quek AM; Weinshenker BG; Wingerchuk DM; Shuster EA; Lucchinetti CF; Pittock SJ
    JAMA Neurol; 2014 Jan; 71(1):48-54. PubMed ID: 24248262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
    Waters P; Reindl M; Saiz A; Schanda K; Tuller F; Kral V; Nytrova P; Sobek O; Nielsen HH; Barington T; Lillevang ST; Illes Z; Rentzsch K; Berthele A; Berki T; Granieri L; Bertolotto A; Giometto B; Zuliani L; Hamann D; van Pelt ED; Hintzen R; Höftberger R; Costa C; Comabella M; Montalban X; Tintoré M; Siva A; Altintas A; Deniz G; Woodhall M; Palace J; Paul F; Hartung HP; Aktas O; Jarius S; Wildemann B; Vedeler C; Ruiz A; Leite MI; Trillenberg P; Probst M; Saschenbrecker S; Vincent A; Marignier R
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1005-15. PubMed ID: 27113605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
    Pisani F; Settanni P; Rosito S; Mola MG; Iorio R; Tortorella C; Ruggieri M; Trojano M; Svelto M; Frigeri A; Nicchia GP
    PLoS One; 2015; 10(11):e0143679. PubMed ID: 26599905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.